From Hell To Veins

April 14, 2014

A New Autoimmunity Syndrome Linked to Aluminum In Vaccines

Editors Note:
Aluminum heavy metal poisoning causing any number of auto immune disorders has been known for decades. Volumes of medical literature on this subject is easily available to anyone who has any doubt or questions. I strongly suggest to mothers to read the ingredients in the vaccines FOR YOURSELF, look up aluminum heavy metal poisoning then, take a good look at your baby in the eyes and ask… “Do I really want to inject that garbage into his / her veins?”

All sourced links are found at original article linked below.
A New Autoimmunity Syndrome Linked to Aluminum In Vaccines

While “anti-vaxxers” are being smeared in public campaigns as backward and unscientific fear-mongers, a growing body of cutting edge research is emerging from the top echelons of medical immunology to confirm what the cranks have been saying for years about the devastating effects of vaccine ingredients. The biggest names in the field of study of the human immune system are attached to current papers in the most prestigious immunology literature that link widely used vaccine ingredients such as aluminum to terrifying modern epidemics of immune-mediated diseases including autism and Alzheimer’s. As well, they’ve identified an entirely new post-vaccine syndrome: Autoimmune Inflammatory Syndrome Induced by Adjuvants (ASIA). And while the study of ASIA is shining light on the underlying mechanisms through which vaccine ingredients trigger disease, it is also exposing cracks in the foundation of a century of vaccine orthodoxy .

Nearly 3,000 doctors and scientists from around the world gathered last week at the 9th International Congress on Autoimmunity (ICA) in the Nice Acropolis Convention Center on the French Riviera. Dozens of seminars and panel discussions of causes and treatments for scores of autoimmune diseases were scheduled. But an entire day of the four day event held every two years was devoted to the 3rd International Vaccine Symposium held under the umbrella of the ICA.

Ignasi Rodriguez-Pinto, an autoimmunologist at the Barcelona Hospital Clinic and former fellow of the pre-eminent Zabludowicz Center for Autoimmune Diseases at Tel Aviv University’s Sheba Medical Center was at the symposium to announce the creation of a world registry for ASIA.

ASIA was first identified in the Journal of Autoimmunology in 2011 by Dr. Yehuda Schoenfeld, founder of the Zabludowicz Center. It includes a broad spectrum of neurological and immune-mediated phenomena seen following vaccine injections which result from exposure to their ingredients, including aluminum. Among ASIA’s diagnostic criteria: weakness, anxiety, rashes, chronic fatigue, sleep disorders and the onset of a range of autoimmune diseases from Systemic Lupus Erythematosis to Rheumatoid Arthritis — sometimes years after an initial reaction.

ASIA is also dubbed “Schoenfeld’s Syndrome” for Schoenfeld who has published more than 1,700 articles in the medical literature and is widely regarded as the world’s leading authority on autoimmunity — disease that results when certain proteins in the body lose their “immune privilege” or protected status, and the machinery of the human defence system mistakes them as foreign invaders and launches an assault on its own body.

“ASIA is a wide concept that includes any environmental factor which is demonstrated to trigger autoimmune conditions,” said Rodriguez-Pinto. Cases of Gulf War Syndrome, which result from exposure to the chemical squalene – a component of vaccines used on military personnel during the Gulf War, and siliconosis – immune-mediated symptoms triggered by silicon exposure in prostheses and breast implants – are now being considered under ASIA’s umbrella, he said.

The registry was established in January of this year as a tool to enable researchers to analyze cases of ASIA globally, to compare clinical manifestations after exposure, and to establish common instigators of autoimmunity and compare efficacy of treatments. In its first month of operation, 283 confirmed cases of the syndrome were registered — 73% followed vaccination while the remainder were exposed to other known toxins.

Most currently registered cases of ASIA have followed vaccination for Hepatitis B (70.7 percent), said Rodriguz- Pinto. Forty percent of the cases developed defined autoimmune conditions including Multiple Sclerosis and a subgroup of 20 percent had more than one diagnosed autoimmune disease.

“Adjuvants have been used for decades to improve the immune response to vaccines, and among this large group, alumimum and silicone are most commonly described,” explains a paper in the July 2013 Immunologic Research, penned by four leading immunologists including Schoenfeld. “Nonetheless, as supported by increasing reports, although rarely vaccines are able to trigger the development of [autoimmune diseases] ADs in genetically susceptible humans, this could be ascribed to the presence of containing adjuvants. The time relationship between the vaccine delivery and overt disease can last from a few weeks to even years.”

The paper adds that a “now abundant literature shows that exposure of human and animals to aluminum from various sources can have deleterious consequences on the nervous system, especially in adults.”

Among the authors of that abundant literature is Canada’s Christopher Shaw, chairman of the Children’s Medical Safety Research Institute and a researcher at the University of British Columbia who , at the IAC last week described aluminum as “insidiously unsafe.”

“That the aluminum ion is very toxic is well known,” said Shaw. “Its toxicity was recognized as long ago as 1911 and evidence of that has only been amplified since,” he said, especially in a growing body of evidence of aluminum’s role in Alzheimer’s disease and autism.

Though found in some food and water sources, since the 1920s, aluminum has been used in many and a growing number of vaccines, Shaw said, and “the compartment in which you put it in and the route of administration makes all the difference.”

“Aluminum is a demonstrated neurotoxin,” he added. “From the molecular level between ions and molecules, to the genome, to the protein and cellular level to the circuit level, there is no level of the nervous system that aluminum does not negatively impact.”

Shaw reported on his research on mice injected with aluminum doses equivalent to those in vaccine injections. They showed progressive loss of muscle strength and endurance, and at the cellular level, “profound loss of motor neurons.”

He and other researchers also demonstrated “social interaction deficits” and elevated anxiety levels among the vaccinated mice, reflected by their obsessive stair climbing and reluctance to move between light and dark regions compared to controls, for example. Shaw’s forthcoming research demonstrates the impact of aluminum on gene proteins and gene expression and how these relate to autism.

Celeste McGovern’s article first appeared on GreenMedInfo.


April 27, 2012

Can We Continue To Justify Injecting Aluminum Into Children?

Filed under: HOME — nwqfk @ 3:15 p04
Tags: ,

Editor’s Note:
Injecting aluminum into the veins causes the body to react to heavy metal poisoning and does NOT mean you will become immune to disease as a result. The reaction to aluminum adjuvants in vaccines by the body is a cytokine storm spectrum. No killer T cells have EVER been produced to fight disease by this method. This is why the vaccine industry wants to play with fire by giving LIVE virus vaccines to people. There is an entire genetically altered nano technology emerging that is even more frightening but, that will have to be covered at a later time.

Can We Continue To Justify Injecting Aluminum Into Children?

Sayer Ji
April 27, 2012
A new report published in the Journal of Trace Elements in Medicine and Biology raises a disturbing possibility: that aluminum hydroxide, the dominant metal-based adjuvant used in vaccines today, is causing aluminum overload at injection sites, and contributing to the pathogenesis of diseases such as chronic fatigue syndrome, macrophagic myofasciitis and subcutaneous pseudolymphoma. [i]

Discussed is the case of a 45-year old woman with vaccine-induced subcutaneous pseudolymphoma, a type of skin lesion characterized by collections of lymphocytes, macrophages, and dendritic cells in the skin. The researchers performed a skin biopsy at the injection site and found aluminum (AI) deposits in her macrophages. When the skin sample was assayed for AI and quantified, it was found to contain 768.1 micrograms per gram, dry weight, versus 5.61 and 9.13 in two control patients – up to 153-fold higher concentrations.

The report cautioned: “Given the pathology of this patient and the high Al concentration in skin biopsy, the authors wish to draw attention when using the Al salts known to be particularly effective as adjuvants in single or repeated vaccinations. The possible release of Al may induce other pathologies ascribed to the well-known toxicity of this metal.”

As referenced, aluminum-based (and other) vaccine adjuvants are “effective” at increasing antibody titers, but they perform this feat through the hypersensitization and/or dysregulation of the humoral pole of the immune system (Th2), which is the immunological equivalent of kicking a beehive.

While intrinsically toxic adjuvants enable manufacturers to produce more antibodies with less antigen (often a profit-motivated decision), these synthetically-generated increases in the sheer number of antibodies produced does not in any way guarantee they will target the correct antigen (i.e. antibody-antigen affinity), which is the true measure of vaccine effectiveness; in fact, these unnaturally stimulated antibodies cross-react with and/or attack self-structures, e.g. myelin basic protein, leading to the break down of immunological self-tolerance, i.e. autoimmunity.

It is a curious fact of vaccine history that while aluminum hydroxide has been injected into billions of people and has been used for almost one century as the only vaccine adjuvant approved worldwide, its mechanism of action is not fully understood, and is only being investigated with any depth in the past five years.

We know that one way in which aluminum hydroxide induces an enhanced immune response is through activating the inflammasome within myeloid cells, a key immune-mediated activator of the inflammatory response and which is known to induce cell death. And yet, without understanding its exact mechanism of action, it is impossible by principle to ascertain fully its risk to health.

Last year, a report published in the journal Current Medicinal Chemistry titled “Aluminum vaccine adjuvants: are they safe?” raised these safety concerns:

Aluminum is an experimentally demonstrated neurotoxin and the most commonly used vaccine adjuvant. Despite almost 90 years of widespread use of aluminum adjuvants, medical science’s understanding about their mechanisms of action is still remarkably poor. There is also a concerning scarcity of data on toxicology and pharmacokinetics of these compounds. In spite of this, the notion that aluminum in vaccines is safe appears to be widely accepted. Experimental research, however, clearly shows that aluminum adjuvants have a potential to induce serious immunological disorders in humans. In particular, aluminum in adjuvant form carries a risk for autoimmunity, long-term brain inflammation and associated neurological complications and may thus have profound and widespread adverse health consequences. In our opinion, the possibility that vaccine benefits may have been overrated and the risk of potential adverse effects underestimated, has not been rigorously evaluated in the medical and scientific community. [ii]

Another study published in 2011 in the Journal of Inorganic Biochemistry brought up the taboo topic of vaccine-induced autism, focusing on the crucial role of aluminum adjuvants as neurotoxic agents. The study abstract is well worth reading, as you will not see this type of information reported anywhere in the mainstream media:

Autism spectrum disorders (ASD) are serious multisystem developmental disorders and an urgent global public health concern. Dysfunctional immunity and impaired brain function are core deficits in ASD. Aluminum (Al), the most commonly used vaccine adjuvant, is a demonstrated neurotoxin and a strong immune stimulator. Hence, adjuvant Al has the potential to induce neuroimmune disorders. When assessing adjuvant toxicity in children, two key points ought to be considered: (i) children should not be viewed as “small adults” as their unique physiology makes them much more vulnerable to toxic insults; and (ii) if exposure to Al from only few vaccines can lead to cognitive impairment and autoimmunity in adults, is it unreasonable to question whether the current pediatric schedules, often containing 18 Al adjuvanted vaccines, are safe for children? By applying Hill’s criteria for establishing causality between exposure and outcome we investigated whether exposure to Al from vaccines could be contributing to the rise in ASD prevalence in the Western world. Our results show that: (i) children from countries with the highest ASD prevalence appear to have the highest exposure to Al from vaccines; (ii) the increase in exposure to Al adjuvants significantly correlates with the increase in ASD prevalence in the United States observed over the last two decades (Pearson r=0.92, p<0.0001); and (iii) a significant correlation exists between the amounts of Al administered to preschool children and the current prevalence of ASD in seven Western countries, particularly at 3-4 months of age (Pearson r=0.89-0.94, p=0.0018-0.0248). The application of the Hill’s criteria to these data indicates that the correlation between Al in vaccines and ASD may be causal. Because children represent a fraction of the population most at risk for complications following exposure to Al, a more rigorous evaluation of Al adjuvant safety seems warranted.[iii]

Another, even more taboo topic is vaccine-induced infant death, which is often forced into the “idiopathic” category of Sudden Infant Death Syndrome (SIDS). A report published in the Journal of Tropical Medicine in 2011, offers an explanation for the well-known, though often censored link between DTP vaccines used in the third world and increased mortality in female infants.[iv]

Titled “Immunological Links to Nonspecific Effects of DTwP and BCG Vaccines on Infant Mortality,” researchers reported on the fact that “A number of mainly observational studies suggest that many African females below the age of one year die each year from the nonspecific effects of vaccination with diphtheria-tetanus toxoids and killed (whole-cell) Bordetella pertussis (DTwP).”

The explanation they offered is that “…the adverse effects of DTwP vaccine may occur because of the Th2-polarising effect of the aluminium phosphate adjuvant in the vaccine and because intramuscular administration of the vaccine may cause chronic inflammation at the site of injection.”

Aluminum has no known beneficial function in biology. Increasing awareness of this metal’s role in breast cancer, due to its metalloestrogenic properties, and its prevalence in our food (baking soda), body care products (e.g. antiperspirants), drugs and environment (e.g. it is used in aerosolized form in military operations as aluminized chaff), is bringing to light how important it is to avoid unnecessary exposures, especially when it concerns the health of our infants and children who are already faced with an ever-increasing body burden of this, and other highly toxic metals. It is clear that if we implement the precautionary principle, vaccines which contain this, or any other, highly toxic metal should be avoided at all costs.

Blog at